Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CTMX
#2657
CytomX Therapeutics, Inc.
4.3
9
USD
0.00%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
0.00%
Mudança mensal
-36.47%
Mudança em 6 meses
+26.88%
Mudança anual
+608.06%
Fechamento anterior
4.3
9
Abrir
4.3
5
Bid
Ask
Mínimo
4.3
1
High
4.3
9
Volume
804
Mercados
Ações
Cuidados de saúde
CTMX
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
64.78 M
65.39 M
66.23 M
67.72 M
80.1 M
170.19 M
—
Valuation ratios
Enterprise value
232.48 M
77.62 M
-87.02 M
97.28 M
44.45 M
712.33 M
1.55 B
Price to earnings ratio
—
—
-1.07
-169
2.71
-28.4
-15.05
Price to sales ratio
—
—
1.99
1.23
0.63
7.71
12.15
Price to cash flow ratio
—
—
-0.96
-2.23
-1.01
-7.77
-15.75
Price to book ratio
—
—
-1.23
-2.63
-191.42
5.93
8.31
Enterprise value to EBITDA ratio
-5.02
-0.96
0.88
-8.27
2.07
-30.67
1.18
Profitability ratios
Return on assets %
-0.09
-0.25
-0.38
-0
0.26
-0.11
-0.03
Return on equity %
-0.66
-0.94
1.16
0.01
-69.89
-0.18
0.54
Return on invested capital %
-137.42
-322.4
-333.03
2.95
82.29
-145.89
-351.48
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-48.43
-120.42
-190.61
-6.41
18.1
-29.35
-4 439.72
EBITDA margin %
-46.13
-116.08
-186.11
-11.62
15.52
-30.48
-4 537.54
Net margin %
-32.77
-120.17
-186.82
-0.56
23.08
-22.79
-4 191.74
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
3.21
2.92
1.55
1.17
1.25
3.09
12.65
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.29
0.2
0.18
0.44
0.86
0.56
0.64
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-1.69
-0.76
-1.02
-0.55
-0.63
EBIT per share
—
—
-1.54
-0.09
0.29
-0.16
-0.05
EBITDA per share
—
—
-1.51
-0.16
0.25
-0.17
-0.06
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.45
2.38
1.2
0.99
4.01
Net current asset value per share
—
—
3.61
2.48
1.27
1.04
4.22
Tangible book value per share
—
—
-1.33
-0.67
-0.02
0.71
2.54
Working capital per share
—
—
1.29
0.37
0.25
0.71
2.75
Book value per share
—
—
-1.3
-0.64
-0.01
0.72
2.59
Notícias
Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?
Jefferies reitera recomendação de compra para CytomX após dados da fase 1
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts - TipRanks.com
Piper Sandler eleva preço-alvo das ações da CytomX com base em dados de ensaios clínicos
Jefferies eleva preço-alvo das ações da CytomX após dados de ADC
CytomX precifica oferta de ações de US$ 250 milhões a US$ 5,30 por ação
CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data
CytomX Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:CTMX) 2026-03-17
CytomX launches $250M public offering to fund drug development
Micron and Intel among market cap stock movers on Monday
CytomX: The Probody Mask Just Slipped, And Investors Like What They See (Upgrade) (CTMX)
Micron, Intel among market cap stock movers on Monday